The feasibility of using eye‐tracking technology for cognitive screening in Down syndrome with dementia: A cross‐sectional case series
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Helen Lindner und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: Down Syndrome, Dementia, Eye-Tracking Technology, Eye Movements. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Örebro County research committee, ALF funding, Region Örebro County, Stiftelsen Promobilia.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Adults with Down syndrome (DS) are at a high risk for dementia, yet cognitive screening is complicated by premorbid intellectual disabilities. This study evaluated the feasibility of using eye‐tracking technology as a screening tool. METHODS Ten adults with DS (five with dementia, five without) completed cognitive tasks while their eye movements were recorded. Feasibility was assessed through calibration success, gaze sample quality, and task completion. RESULTS Calibration was successful for most subjects (except one individual with dementia required five attempts and had low gaze sampling). Most subjects achieved 50%–88% gaze sample rates and completed testing with staff support. Subjects with dementia showed longer times to first fixation but similar fixation durations compared to those without dementia. Cognitive scores were lower in the dementia group but not significantly correlated with gaze quality. DISCUSSION Eye tracking may be a feasible method for cognitive screening in DS, but further validation is needed. Highlights Eye‐tracking may be a potential non‐verbal method for cognitive screening in individuals with DS. Support from staff for engaging the subjects could be essential for maintaining attention on the computer screen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- The Laboratory for Visual Neuroplasticity, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
- University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
ORCID-Profile: Helen Lindner
Förderung
- Region Örebro County research committee
- ALF funding, Region Örebro County
- Stiftelsen Promobilia
Zitieren
APA
Lindner, H., Merabet, L. B., & Lundqvist, L. O. (2025). The feasibility of using eye‐tracking technology for cognitive screening in Down syndrome with dementia: A cross‐sectional case series. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70385
Vancouver
Lindner H, Merabet LB, Lundqvist LO. The feasibility of using eye‐tracking technology for cognitive screening in Down syndrome with dementia: A cross‐sectional case series. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70385
BibTeX
@article{Lindner2025,
author = {Lindner, Helen and Merabet, Lotfi B and Lundqvist, Lars-Olov},
title = {The feasibility of using eye‐tracking technology for cognitive screening in Down syndrome with dementia: A cross‐sectional case series},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70385}
}
EUVIMED